Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Goldman Sachs Downgrades Vitru to Neutral

Goldman Sachs analyst Irma Sgarz downgrades Vitru (NASDAQ:VTRU) from Buy to Neutral.

October 11, 2022

1 minute read

Goldman Sachs analyst Irma Sgarz downgrades Vitru (NASDAQ:VTRU) from Buy to Neutral.

Piper Sandler Maintains Neutral on Solid Biosciences, Lowers Price Target to $2

Today, 6:14 AM

Piper Sandler analyst Allison Bratzel maintains Solid Biosciences (NASDAQ:SLDB) with a Neutral and lowers the price target from $5 to $2.

Today, 6:14 AM

-Reuters

Today, 6:14 AM

UBS maintains Nutrien (NYSE:NTR) with a Buy and raises the price target from $88 to $93.

Today, 6:14 AM

Cardinal Health Inc (NYSE:CAH) has reported Q4 FY22 adjusted EPS of $1.05, up 36% Y/Y, missing the consensus of $1.17.…